Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Teija Ojala"'
Autor:
Severi Mulari, Arda Eskin, Milla Lampinen, Annu Nummi, Tuomo Nieminen, Kari Teittinen, Teija Ojala, Matti Kankainen, Antti Vento, Jari Laurikka, Markku Kupari, Ari Harjula, Nurcan Tuncbag, Esko Kankuri
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Although many pathological changes have been associated with ischemic heart disease (IHD), molecular-level alterations specific to the ischemic myocardium and their potential to reflect disease severity or therapeutic outcome remain uncle
Externí odkaz:
https://doaj.org/article/e5a77ca58bb24552a5fdc0c04e5ca02e
Autor:
Olli Dufva, Matti Kankainen, Tiina Kelkka, Nodoka Sekiguchi, Shady Adnan Awad, Samuli Eldfors, Bhagwan Yadav, Heikki Kuusanmäki, Disha Malani, Emma I Andersson, Paavo Pietarinen, Leena Saikko, Panu E. Kovanen, Teija Ojala, Dean A. Lee, Thomas P. Loughran, Hideyuki Nakazawa, Junji Suzumiya, Ritsuro Suzuki, Young Hyeh Ko, Won Seog Kim, Shih-Sung Chuang, Tero Aittokallio, Wing C. Chan, Koichi Ohshima, Fumihiro Ishida, Satu Mustjoki
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Aggressive natural killer-cell leukemia (ANKL) has few targeted therapies. Here ANKL patients are reported to harbor STAT3, RAS-MAPK pathway, DDX3X and epigenetic modifier mutations; and drug sensitivity profiling uncovers the importance of the JAK-S
Externí odkaz:
https://doaj.org/article/a90516e221ea4f0c9791e1e130cc3ead
Publikováno v:
Trends in Molecular Medicine. 29:376-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42868f6595dd554a70835add3ce4e044
https://doi.org/10.1016/j.molmed.2023.02.002
https://doi.org/10.1016/j.molmed.2023.02.002
Autor:
Matti Kankainen, Teija Ojala, Mahmoud M. Kamel, Samuli Eldfors, Caroline A. Heckman, Soili Kytölä, Kimmo Porkka, Ashwini Kumar, Perttu Koskenvesa, Satu Mustjoki, Bishwa Ghimire, Shady Adnan Awad
Publikováno v:
Blood Advances. 4:546-559
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm accounting for ∼15% of all leukemia. Progress of the disease from an indolent chronic phase to the more aggressive accelerated phase or blast phase (BP) occurs in a minority of cases a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c853f82bff492bdfa493598db70931d5
https://doi.org/10.1182/bloodadvances.2019000943
https://doi.org/10.1182/bloodadvances.2019000943
Abstract 12866: Ischemic Heart Disease Selectively Modifies The Right Atrial Appendage Transcriptome
Autor:
Severi Mulari, Arda Eskin, Milla Lampinen, Annu Nummi, Tuomo Nieminen, Kari Teittinen, Teija Ojala, Matti Kankainen, Antti Vento, Jari Laurikka, Markku Kupari, Ari Harjula, Nurcan Tunçbag, Esko Kankuri
Publikováno v:
Circulation. 144
Introduction: Although many pathological changes have been associated with ischemic heart disease (IHD), molecular-level alterations specific to the ischemic myocardium and their potential to reflect disease severity or therapeutic outcome remain unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21f237eddfc272499a947348f8e71e0d
https://doi.org/10.1161/circ.144.suppl_1.12866
https://doi.org/10.1161/circ.144.suppl_1.12866
Autor:
Liisa Holm, Matti Kankainen, Andrew Lindford, Jyrki Vuola, Kirsi Savijoki, Esko Kankuri, Alan Medlar, Pekka Varmanen, Teija Ojala, Heli Lagus, Pentti Kuusela, Jenni J. Tommila
Publikováno v:
Clinical Microbiology and Infection. 27:144-146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d53d3f183050119520847944f499f
https://doi.org/10.1016/j.cmi.2020.07.021
https://doi.org/10.1016/j.cmi.2020.07.021
Autor:
Satu Mustjoki, Bhagwan Yadav, Young Hyeh Ko, Samuli Eldfors, Emma I. Andersson, Koichi Ohshima, Panu E. Kovanen, Disha Malani, Olli Dufva, Hideyuki Nakazawa, Paavo Pietarinen, Nodoka Sekiguchi, Leena Saikko, Junji Suzumiya, Thomas P. Loughran, Matti Kankainen, Ritsuro Suzuki, Dean A. Lee, Wing C. Chan, Heikki Kuusanmäki, Shih-Sung Chuang, Teija Ojala, Shady Adnan Awad, Fumihiro Ishida, Won Seog Kim, Tiina Kelkka, Tero Aittokallio
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications
Nature Communications
Aggressive natural killer-cell (NK-cell) leukemia (ANKL) is an extremely aggressive malignancy with dismal prognosis and lack of targeted therapies. Here, we elucidate the molecular pathogenesis of ANKL using a combination of genomic and drug sensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebbd4a5bdf7fb8304c0caf1f86741a8b
https://doaj.org/article/a90516e221ea4f0c9791e1e130cc3ead
https://doaj.org/article/a90516e221ea4f0c9791e1e130cc3ead
Autor:
Saara Pitkänen, Petri Auvinen, Lars Paulin, Matti Kankainen, Pia Laine, Tuomas Salusjärvi, Terhi Ahlroos, Jarna Tanskanen, Teija Ojala, Soile Tynkkynen
Publikováno v:
International Journal of Food Microbiology. 241:39-48
Propionibacterium freudenreichii is a commercially important bacterium that is essential for the development of the characteristic eyes and flavor of Swiss-type cheeses. These bacteria grow actively and produce large quantities of flavor compounds du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b9e851b52047e57ead450013e2bcf8
https://doi.org/10.1016/j.ijfoodmicro.2016.09.022
https://doi.org/10.1016/j.ijfoodmicro.2016.09.022
Autor:
Pirkko Mattila, Rainer Krebs, Antti I. Nykänen, E. Holmström, Teija Ojala, Karl B. Lemström, Kishor Dhaygude, J. Lukac, Matti Kankainen
Publikováno v:
Transplantation. 104:S168-S168
Purpose Numerous studies have shown that statin therapy initiated early after heart transplantation has beneficial effects on the development of cardiac allograft vasculopathy. Recently, we were able to show in a randomized clinical trial that simvas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc0e1efd9f2b7c48846721778782499
https://doi.org/10.1097/01.tp.0000699196.59710.2b
https://doi.org/10.1097/01.tp.0000699196.59710.2b
Autor:
Jukka Y. A. Lehtonen, Markku Kupari, Esko Kankuri, Matti Kankainen, Piia Simonen, Teija Ojala
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1730abe04a53cd6ee284df6dbb9d97de
https://doi.org/10.1093/eurheartj/ehy565.p1606
https://doi.org/10.1093/eurheartj/ehy565.p1606